Immunisation against meningococcus B.

Blewitt, Jane

Blewitt, Jane.

Lancet ; 382(9895): 857-8, 2013 Sep 07.

Article in En | MEDLINE | ID: mdl-24012267

Subject(s)

Carrier State/immunology; Carrier State/prevention & control; Meningitis, Meningococcal/immunology; Meningitis, Meningococcal/prevention & control; Meningococcal Vaccines/administration & dosage; Meningococcal Vaccines/immunology; Neisseria meningitidis, Serogroup B/immunology; Adolescent; Carrier State/economics; Cluster Analysis; Cost-Benefit Analysis; Cross-Sectional Studies; Humans; Immunization, Secondary/economics; Male; Meningitis, Meningococcal/economics; Meningitis, Meningococcal/epidemiology; Meningococcal Vaccines/economics; State Medicine/economics; United Kingdom; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Carrier State / Meningococcal Vaccines / Neisseria meningitidis, Serogroup B / Meningitis, Meningococcal Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Humans / Male Country/Region as subject: Europa Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google